Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach.
BACKGROUND
Drug metabolism and pharmacokinetic (DMPK) assessment has come to occupy a place of interest during the early stages of drug discovery today. Computer-based methods are slowly gaining ground in this area and are often used as initial tools to eliminate compounds likely to present uninteresting pharmacokinetic profiles and unacceptable levels of toxicity from the list of potential drug candidates, hence cutting down the cost of the discovery of a drug.


RESULTS
In the present study, we present an in silico assessment of the DMPK profile of our recently published natural products database of 1,859 unique compounds derived from 224 species of medicinal plants from the Cameroonian forest. In this analysis, we have used 46 computed physico-chemical properties or molecular descriptors to predict the absorption, distribution, metabolism and elimination (ADME) of the compounds. This survey demonstrated that about 50% of the compounds within the Cameroonian medicinal plant and natural products (CamMedNP) database are compliant, having properties which fall within the range of ADME properties of >95% of currently known drugs, while >73% of the compounds have ≤2 violations. Moreover, about 72% of the compounds within the corresponding 'drug-like' subset showed compliance.


CONCLUSIONS
In addition to the previously verified levels of 'drug-likeness' and the diversity and the wide range of measured biological activities, the compounds in the CamMedNP database show interesting DMPK profiles and, hence, could represent an important starting point for hit/lead discovery from medicinal plants in Africa.
CEPAMOQ, Faculty of Science, University of Douala, P,O, Box 8580, Douala, Cameroon. ntiekfidele@gmail.com.
Fidele
F
Ntie-Kang
James A
JA
Mbah
Lydia L
LL
Lifongo
Luc C
LC
Owono Owono
Eugene
E
Megnassan
Luc
L
Meva'a Mbaze
Philip N
PN
Judson
Wolfgang
W
Sippl
Simon Mn
SM
Efange